This case-control study, comprising 106 Portuguese bladder cancer patients and 199 cancer-free control individuals, focused on exploiting the relevance of two genetic variants of HOTAIR—an acknowledged oncogenic molecule in bladder cancer [23,24,26,29]—in the risk and prognosis of bladder cancer patients. Here, HOTAIR is linked to urinary bladder cancer.